← All trials
NCT00209833
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 1999
- Primary completion
- —
- Completion date
- Sep 1, 2005
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Gottfried Wilhelm Leibniz Universität HannoverLead sponsor
- University of UlmCollaborator
- University of FreiburgCollaborator
- Ghent UniversityCollaborator
- Ev. Krankenhaus Essen-WerdenCollaborator
- University of Witten/HerdeckeCollaborator
- J. W. Goethe UniversityCollaborator
- Ludwig Maximilians UniversityCollaborator
- University of HamburgCollaborator
- Gottfried Wilhelm Leibniz Universität HannoverOverall official - principal investigator
- Gottfried Wilhelm Leibniz Universität HannoverCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.